1. 2025
  2. The Persistence of Cross-Reactive Immunity to Influenza B/Yamagata Neuraminidase Despite the Disappearance of the Lineage: Structural and Serological Evidence

    Desheva, Y., Kudar, P., Sergeeva, M., Wong, P., Shvedova, T., Bazhenova, E., Krylova, E., Kurpiaeva, M., Romanovskaya-romanko, E., Krivitskaya, V., Kudria, K., Isakova-sivak, I. & Stukova, M., 2 Aug 2025, In: International Journal of Molecular Sciences. 26, 15, 7476.

    Research output: Contribution to journalArticlepeer-review

  3. 2024
  4. Neuraminidase Antibody Response to Homologous and Drifted Influenza A Viruses After Immunization with Seasonal Influenza Vaccines

    Desheva, Y., Sergeeva, M., Kudar, P., Rekstin, A., Romanovskaya-romanko, E., Krivitskaya, V., Kudria, K., Bazhenova, E., Stepanova, E., Krylova, E., Kurpiaeva, M., Lioznov, D., Stukova, M. & Kiseleva, I., 2024, In: Vaccines. 12, 12, 16 p., 1334.

    Research output: Contribution to journalArticlepeer-review

  5. 2020
  6. A phase 1 randomized placebo-controlled study to assess the safety, immunogenicity and genetic stability of a new potential pandemic H7N9 live attenuated influenza vaccine in healthy adults

    Kiseleva, I., Isakova-Sivak, I., Stukova, M., Erofeeva, M., Donina, S., Larionova, N., Krutikova, E., Bazhenova, E., Stepanova, E., Vasilyev, K., Matyushenko, V., Krylova, M., Galatonova, J., Ershov, A., Lioznov, D., Sparrow, E. G., Torelli, G. & Rudenko, L., Jun 2020, In: Vaccines. 8, 2, p. 1-20 20 p., 296.

    Research output: Contribution to journalArticlepeer-review

ID: 50585405